Investor Relations

It becomes abundantly clear that traditional Chinese medicines (TCM) is going to be the next modality and prescribed TCM formulas will be viewed as powerful therapeutic cures. Dragon Jade pioneering endeavors in promoting better access and broader use of TCM will definitely be paid off and return of investments should be remarkable.

Dragon Jade in-depth understanding of how to carry out biomedical experimentation, clinical traits, systematic reviews and sampled surveys will surely help its selected traditional Chinese medicines partner companies to meet the western scientific disciplines of medicines or healthcare products.

Dragon Jade has extensive know- how techniques to implement and comply with the prescribed codes of practices and relevant laws and ordinances. These merits will definitely attract generous funds and revenues in the near future for there are far too many TCM companies are eager to seek assistance to help them deal with the tough FDA regulatory regime.

As a public company, Dragon Jade uses a transfer agent to maintain a record of the institutions and individuals that own Dragon Jade stock. The transfer agent also assists the company by acting as an intermediary to issue certificates to reflect ownership changes, handle certificates that require re-issue, and other important securities functions. Dragon Jade uses Pacific Stock Transfer Company as the company’s transfer agent.